EFFICACY AND SAFETY IN HIGH‐RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB. (12th June 2019)

• Record Type: Journal Article
• Authors: Dreyling, M.; Santoro, A.; Leppä, S.; Demeter, J.; Follows, G.A.; Lenz, G.; Kim, W.S.; Mollica, L.; Nagler, A.; Phipps Diong, C.; Provencio, M.; Magagnoli, M.; Munoz, J.; Hiemeyer, F.; Liu, L.; Miriyala, A.; Rodrigues, L.; Garcia‐Vargas, J.; Childs, B.H.; Zinzani, P.L.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 387
• Page End: 389
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.57_2631
• Languages: English
• ISSNs: 0278-0232